CASP9 and esophageal squamous cell carcinoma: For instance, a study by Zou et al. [33] reported that gimatecan induces apoptosis in esophageal squamous cell carcinoma cell lines in vitro by increasing Bax expression, activating cleaved caspase-3 and cleaved-caspase-9, and reducing Bcl-2 expression.